This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Inter Parfums' (IPAR) Subsidiary to Buy Office Building Complex
by Zacks Equity Research
Inter Parfums' (IPAR) subsidiary Interparfums SA to buy property in Paris, which will be used as its headquarters. Management expects to close the transaction during spring of 2021.
Inter Parfums (IPAR) Up 3.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Inter Parfums (IPAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Inter Parfums (IPAR) Offers 2021 View, Product Launches on Track
by Vrishali Bagree
Inter Parfums' (IPAR) 2021 guidance indicates sales and earnings growth. The company is set to strengthen its brand portfolio through product introductions in 2021.
Estee Lauder (EL) Gains on Solid Online Business & Savings
by Zacks Equity Research
Estee Lauder (EL) is benefiting from its robust e-commerce business, especially amid the COVID-19 outbreak. Also, its solid presence in emerging markets is impressive.
Nu Skin (NUS) Looks Radiant on Innovation & Digital Strength
by Zacks Equity Research
Nu Skin (NUS) has been gaining on initiatives to strengthen sales leader and expand customer base through product launches. Also, the company's focus on digital operations bodes well.
Is Colgate (CL) Benefiting From Healthy Consumer Good Demand?
by Zacks Equity Research
Colgate (CL) benefits from the increase in demand for personal and home care products due to the pandemic-led increase in hygiene habits.
Earnings Estimates Moving Higher for Inter Parfums (IPAR): Time to Buy?
by Zacks Equity Research
Inter Parfums (IPAR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Inter Parfums (IPAR) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Inter Parfums (IPAR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Inter Parfums (IPAR) Q3 Earnings Beat Estimates, Sales Down
by Zacks Equity Research
Inter Parfums' (IPAR) third-quarter 2020 sales and earnings fall year over year. Nevertheless, results reflect sequential growth as stores reopened and e-commerce business was robust.
Inter Parfums (IPAR) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Inter Parfums (IPAR) delivered earnings and revenue surprises of 26.83% and 0.02%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Inter Parfums (IPAR) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Adverse impacts stemming from lack of new product launches in 2020 is likely to get reflected in Inter Parfums' (IPAR) third-quarter 2020 sales.
Why Inter Parfums (IPAR) Might Surprise This Earnings Season
by Zacks Equity Research
Inter Parfums (IPAR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Nu Skin (NUS) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Continued investment in digital capabilities and benefits from robust product portfolio are likely to get reflected in Nu Skin's (NUS) third-quarter 2020 performance.
Inter Parfums (IPAR) Raises 2020 View Despite Soft Q3 Sales
by Zacks Equity Research
Inter Parfums' (IPAR) sales decline year over year across all geographies in third-quarter 2020. Nevertheless, better-than-expected rebound leads management to raise 2020 view.
Simple Market Timing Strategies That Work - September 14, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
by Zacks Equity Research
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
4 Cosmetics Stocks to Buff Up Your Portfolio Amid Industry Challenges
by Zacks Equity Research
The Zacks Cosmetics industry is facing COVID-19 woes like disturbed travel retail, low traffic and soft makeup demand. Rising demand for personal care products however bodes well for HELE, NUS, IPAR and ELF, which are focused on adapting to the changing market trends.
Inter Parfums Down on 2020 View, Travel Retail Woes to Stay
by Zacks Equity Research
Inter Parfums (IPAR) expects net sales of roughly $442 million for 2020, indicating a decline from 2019 levels. Travel retail is likely to remain under pressure.
Why Is Inter Parfums (IPAR) Up 0.4% Since Last Earnings Report?
by Zacks Equity Research
Inter Parfums (IPAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Inter Parfums (IPAR) in Focus: Stock Moves 6.9% Higher
by Zacks Equity Research
Inter Parfums (IPAR) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Timing the Market, Is it Possible? - August 21, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Inter Parfums (IPAR) Posts Narrower-Than-Expected Q2 Loss
by Zacks Equity Research
Inter Parfums' (IPAR) second-quarter 2020 results reflect lower sales thanks to coronavirus-induced retail outlet closures. Also, sales declined across all regions and brands.
Inter Parfums (IPAR) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Inter Parfums (IPAR) delivered earnings and revenue surprises of 37.50% and -0.07%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Inter Parfums (IPAR) Ahead of Earnings?
by Zacks Equity Research
Inter Parfums (IPAR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Factors Likely to Impact Grocery Outlet's (GO) Q2 Earnings
by Zacks Equity Research
Grocery Outlet's (GO) second-quarter 2020 results might reflect gains from coronavirus-led stockpiling. Moreover, its business model and strategic endeavors remain impressive.